By Associate Professor Amany Zekry

Conference Abstracts

Roberts SK; Maharaj A; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo E-L; Philip J; Strasser SI; Stuart K; Thompson A; Tibbals J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Goodwin M; Karapetis C; Levy MT; Muller K; O'Beirne JP; Pryor D; Seow J; Tallis CJ; Butler N; Olynyk JK; Zalcberg J, 2022, 'MONITORING QUALITY OF CARE IN HEPATOCELLULAR CARCINOMA: A MODIFIED DELPHI CONSENSUS', in HEPATOLOGY, WILEY, Vol. 76, pp. S1311 - S1312, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000870796604144&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Shen SS; Jackson M; Khatiwada S; Vijayan A; Raposo A; El-Omar E; Behary J; Zekry A, 2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, presented at Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 2–4 September 2022, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6

Behary J; Raposo A; Zheng H; Amorim N; Gong L; Mcgovern E; Chen J; Liu K; Beretov J; Theocharous C; Jackson M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Defining the temporal evolution of the gut microbiome and associated intrahepatic immune response in the Mdr2-/- model of hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 19, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Behary J; Amorim N; Jiang X; Raposo A; Gong L; Mcgovern E; Chu F; Stephens C; Jebeili H; Fragomeli V; Koay YC; Jackson M; O'Sullivan J; Weltman M; Mccaughan G; El-Omar E; Zekry A, 2020, 'Impact of the gut microbiome and metabolome on the peripheral immune response in non-alcoholic fatty liver disease-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 35, pp. 19 - 20, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000589476200024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Rees V; Behary J; Stephens C; Jebeili H; Szczesniak M; Zekry A; Freiman J, 2019, 'Alterations in metabolic risk factor profile in the transition from non-alcoholic fatty liver disease (NAFLD) to NAFLD-related hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zekry A; Rimassa L; Kelley R; Meyer T; Ryoo B; Merle P; Park J; Blanc J; Lim H; Tran A; Borgman-Hagey A; Clary D; Wang E; Cheng A; El-Khoueiry A; Abou-Alfa G, 2019, 'Outcomes based on plasma biomarkers for the Phase III CELESTIAL trial of cabozantinib versus placebo in advanced hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 41 - 42, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100064&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Kharbat M; Rolls S; Pavendranathan G; Choo L; Zekry A, 2019, 'Virtual clinic for positive fecal occult blood test result: Our local experience', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 34, pp. 238 - 238, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000483843100377&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Factors associated with adherence to hepatocellular carcinoma surveillance in patients undergoing hepatitis B anti-viral therapy in Australia.', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 811A - 811A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sheppard-Law S; Zablotska-Manos I; Kermeen M; Holdaway S; Lee A; Zekry A; George J; Maher L, 2016, 'Predictors of non-adherence to HBV anti-viral therapy', in HEPATOLOGY, WILEY, MA, Boston, Vol. 64, pp. 812A - 812A, presented at 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), MA, Boston, 11 November 2016 - 15 November 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493804004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page